Rocket


News + Filings
Transactions
Holdings





All
13F
13D/G
Other



Foresite Capital Management II, LLC Create: Alert

All | News | Filings
Date FiledTypeDescription
08/11/2023 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
05/12/2023 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
02/13/2023 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
11/14/2022 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
08/12/2022 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
05/13/2022 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
02/11/2022 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
11/12/2021 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
08/13/2021 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
05/14/2021 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
02/16/2021 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
11/13/2020 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
08/13/2020 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
05/14/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/14/2020 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
05/08/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/24/2020 4 Foresite Capital Management I, LLC (10% Owner) has filed a Form 4 on 10x Genomics, Inc.
Txns: Disposed of 700,000 shares @ $0
Acquired 178,584 shares @ $0
Disposed of 178,584 shares @ $0
Acquired 92,258 shares @ $0
Converted 1,000,000 shares @ $0
Converted 1,000,000 options to buy @ $0
04/15/2020 4 Foresite Capital Management I, LLC (10% Owner) has filed a Form 4 on 10x Genomics, Inc.
Txns: Disposed of 788,317 shares @ $0
Disposed of 433,725 shares @ $0
Acquired 201,115 shares @ $0
Disposed of 201,115 shares @ $0
Acquired 21,686 shares @ $0
Disposed of 21,686 shares @ $0
Acquired 109,849 shares @ $0
Converted 1,500,000 shares @ $0
Converted 1,500,000 options to buy @ $0
03/26/2020 4 Foresite Capital Management I, LLC (10% Owner) has filed a Form 4 on 10x Genomics, Inc.
Txns: Converted 2,170,619 shares @ $0
Converted 2,170,619 options to buy @ $0
03/19/2020 4 Foresite Capital Management I, LLC (10% Owner) has filed a Form 4 on 10x Genomics, Inc.
Txns: Converted 1,447,079 shares @ $0
Converted 683,725 shares @ $0
Sold 500,000 shares @ $59, valued at $29.5M
Sold 250,000 shares @ $59, valued at $14.8M
Disposed of 947,079 shares @ $0
Acquired 241,619 shares @ $0
Disposed of 241,619 shares @ $0
Acquired 125,276 shares @ $0
Converted 1,447,079 options to buy @ $0
Converted 683,725 options to buy @ $0
03/02/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/04/2020 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
11/13/2019 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
11/05/2019 3/A Foresite Capital Management II, LLC (10% Owner) has filed a Form 3/A on AERIE PHARMACEUTICALS INC
09/16/2019 4 Foresite Capital Management I, LLC (10% Owner) has filed a Form 4 on 10x Genomics, Inc.
Txns: Bought 187,500 shares @ $39, valued at $7.3M
Converted 5,487,470 convertible preferred @ $0
Converted 1,002,166 convertible preferred @ $0
Converted 558,260 convertible preferred @ $0
Converted 5,513,058 convertible preferred @ $0
Converted 1,324,195 convertible preferred @ $0
Converted 7,047,896 options to buy @ $0
Converted 6,837,253 options to buy @ $0
09/11/2019 3 Form 3 - Initial statement of beneficial ownership of securities:
09/06/2019 4 Foresite Capital Management II, LLC (10% Owner) has filed a Form 4 on AERIE PHARMACEUTICALS INC
Txns: Bought 9,300 shares @ $18.48, valued at $171.9k
Bought 90,900 shares @ $18.48, valued at $1.7M
Bought 15,700 shares @ $18.42, valued at $289.2k
09/04/2019 4 Foresite Capital Management II, LLC (10% Owner) has filed a Form 4 on AERIE PHARMACEUTICALS INC
Txns: Bought 25,000 shares @ $21.36, valued at $534k
Bought 34,900 shares @ $20.54, valued at $716.8k
Bought 15,100 shares @ $21.45, valued at $323.9k
08/23/2019 4 Foresite Capital Management II, LLC (10% Owner) has filed a Form 4 on AERIE PHARMACEUTICALS INC
Txns: Bought 1,153 shares @ $23.25, valued at $26.8k
Bought 6,700 shares @ $23.68, valued at $158.7k
Bought 38,300 shares @ $23.42, valued at $897k
08/20/2019 4 Foresite Capital Management II, LLC (10% Owner) has filed a Form 4 on AERIE PHARMACEUTICALS INC
Txns: Bought 100,000 shares @ $24.23, valued at $2.4M
Bought 3,847 shares @ $23.34, valued at $89.8k
Bought 50,000 shares @ $23.21, valued at $1.2M
08/14/2019 4 Foresite Capital Management II, LLC (10% Owner) has filed a Form 4 on AERIE PHARMACEUTICALS INC
Txns: Bought 189,555 shares @ $24.43, valued at $4.6M
Bought 71,097 shares @ $24.92, valued at $1.8M
Bought 178,903 shares @ $25.52, valued at $4.6M
Bought 100,000 shares @ $23.73, valued at $2.4M
08/14/2019 3 Foresite Capital Management II, LLC (10% Owner) has filed a Form 3 on AERIE PHARMACEUTICALS INC
08/13/2019 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
05/14/2019 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy